RCT in 28,372 women aged 40-74: risk-based breast cancer screening was noninferior to annual mammography for stage IIB or higher cancers (30.0 vs 48.0 per 100,000 person-years) but did not reduce biopsy rates, despite fewer mammograms.
RCTn = 28,372 women
Esserman et al. Risk-Based vs Annual Breast Cancer Screening: The WISDOM Randomized Clinical Trial